Sionna Therapeutics Inc

Research Sionna Therapeutics Inc (SION) on Bullrun: market cap USD 1.94B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSION
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.94B
• Financial periodFY2025
• Net income-USD 75.27M
• Free cash flow-USD 66.67M

Valuation Snapshot

latest market cap is USD 1.94B.

About Sionna Therapeutics Inc

Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF). It develops galicaftor (SION-2222), a transmembrane domain 1 (TMD1)-directed cystic fibrosis transmembrane conductance regulator (CFTR) that has completed Phase 2 trial; navocaftor (SION-3067), a potentiator that has completed Phase 2 trial; SION-109, an intracellular loop 4 directed CFTR corrector that has completed Phase 1 trial;

Frequently asked questions

What is Sionna Therapeutics Inc's market cap?

Sionna Therapeutics Inc's market capitalization is USD 1.94B.

What does Sionna Therapeutics Inc do?

Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF).